Related references
Note: Only part of the references are listed.Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: Interference of AMPK/PGC-1α pathway
Ghorbangol Ashabi et al.
METABOLIC BRAIN DISEASE (2014)
Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering Phenomenon
Hannah J. Whittington et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Effect of iridoid glucoside on plasma lipid profile, tissue fatty acid changes, inflammatory cytokines, and GLUT4 expression in skeletal muscle of streptozotocin-induced diabetic rats
Ramalingam Sundaram et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Effect of catalpol on diabetic nephropathy in rats
Zhao Dong et al.
PHYTOMEDICINE (2013)
AMP-Activated Protein Kinase α1 Protects Against Diet-Induced Insulin Resistance and Obesity
Weiyu Zhang et al.
DIABETES (2012)
Streptozotocin-Induced Cytotoxicity, Oxidative Stress and Mitochondrial Dysfunction in Human Hepatoma HepG2 Cells
Haider Raza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle
A. Franko et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Julia Szendroedi et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Plasma Glucose Lowering Mechanisms of Catalpol, an Active Principle from Roots of Rehmannia glutinosa, in Streptozotocin-Induced Diabetic Rats
Ja-Ping Shieh et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities
William I. Sivitz et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats
Cheng-Fang Wang et al.
BRAIN RESEARCH (2010)
Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle
Carles Canto et al.
CELL METABOLISM (2010)
Antihyperglycemic Effect of Catalpol in Streptozotocin-Induced Diabetic Rats
Wei-Jan Huang et al.
JOURNAL OF NATURAL PRODUCTS (2010)
Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients
Jiankang Liu et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Early transcriptional deregulation of hepatic mitochondrial biogenesis and its consequent effects on murine cholestatic liver injury
Mao-Meng Tiao et al.
APOPTOSIS (2009)
Evaluation of hypoglycemic and anti-hyperglycemic potential of Tridax procumbens (Linn.)
Hemant Pareek et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2009)
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure
Susheel Gundewar et al.
CIRCULATION RESEARCH (2009)
Effects of catalpol on mitochondrial function and working memory in mice after lipopolysaccharide-induced acute systemic inflammation
Aihong Zhang et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2009)
Catalpol attenuates the neurotoxicity induced by β-amyloid1-42 in cortical neuron-glia cultures
Bo Jiang et al.
BRAIN RESEARCH (2008)
Transcriptional control of mitochondrial biogenesis:: the central role of PGC-1α
Renee Ventura-Clapier et al.
CARDIOVASCULAR RESEARCH (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro
Nassima Abdelouahab et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity
H. L. Liang et al.
NEUROSCIENCE (2008)
Catalpol protects mesencephalic neurons against MPTP induced neurotoxicity via attenuation of mitochondrial dysfunction and MAO-B activity
Jing Bi et al.
TOXICOLOGY IN VITRO (2008)
Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals
Christoph Handschin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Efficacy of catalpol as protectant against oxidative stress and mitochondrial dysfunction on rotenone-induced toxicity in mice brain
Yu-Rong Mao et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2007)
Weight gain in type 2 diabetes mellitus
A. N. Jacob et al.
DIABETES OBESITY & METABOLISM (2007)
The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle
Zoltan Arany et al.
CELL METABOLISM (2007)
Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures
Yuan-Yuan Tian et al.
LIFE SCIENCES (2006)
Metformin increases the PGC-1α protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo
Masataka Suwa et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Mitochondrial morphology and distribution in mammalian cells
Ann E. Frazier et al.
BIOLOGICAL CHEMISTRY (2006)
GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1α
Caries Lerin et al.
CELL METABOLISM (2006)
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
JT Rodgers et al.
NATURE (2005)
Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-α
P Puigserver
INTERNATIONAL JOURNAL OF OBESITY (2005)
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
VB Ritov et al.
DIABETES (2005)
OPA1 requires mitofusin 1 to promote mitochondrial fusion
S Cipolat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Biological control through regulated transcriptional coactivators
BM Spiegelman et al.
CELL (2004)
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes:: Potential role of PGC1 and NRF1
ME Patti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes
DE Kelley et al.
DIABETES (2002)
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
J Lin et al.
NATURE (2002)